AIA forces changes in invention capture and review procedures: study

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

AIA forces changes in invention capture and review procedures: study

The America Invents Act has prompted many companies to make changes in their invention capture and review procedures and public disclosure polices, according to a study released by IP advisory firm ipPerformance

Compared to study results released in 2012 before implementation of the AIA, roughly double the companies indicated that they made changes in invention capture and submission stage versus their preparation and filing stage.

Some 85% of companies indicated that the AIA has influenced them to make public disclosure of an invention prior to patent filing policy changes. A third of companies indicated that the increase in USPTO fees will cause an increase to their patent budget.

“America Invents Act has encouraged companies to adapt their procedures, workflows and policies. The increased fees as well as pre and post grant proceedings are major factors that are impacting budgeting and strategy,” said Robert Williamson, president at ipPerformance Group.

Fifty-nine companies representing a variety of industries participated in the study, including Air Liquide, Nova Chemical, Sun Chemical, Dow Corning Corporation, Nova Measuring Instruments, ZBD, Avebe, Sasol, Neste Oil, Micro Encoder, Automotive Technologies and Freescale Semiconductor.

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article